Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders

Marine habitats offer a rich reservoir of new bioactive compounds with great pharmaceutical potential; the variety of these molecules is unique, and its production is favored by the chemical and physical conditions of the sea. It is known that marine organisms can synthesize bioactive molecules to s...

Full description

Bibliographic Details
Main Authors: Mariano Catanesi, Giulia Caioni, Vanessa Castelli, Elisabetta Benedetti, Michele d’Angelo, Annamaria Cimini
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/19/1/24
_version_ 1797414603872796672
author Mariano Catanesi
Giulia Caioni
Vanessa Castelli
Elisabetta Benedetti
Michele d’Angelo
Annamaria Cimini
author_facet Mariano Catanesi
Giulia Caioni
Vanessa Castelli
Elisabetta Benedetti
Michele d’Angelo
Annamaria Cimini
author_sort Mariano Catanesi
collection DOAJ
description Marine habitats offer a rich reservoir of new bioactive compounds with great pharmaceutical potential; the variety of these molecules is unique, and its production is favored by the chemical and physical conditions of the sea. It is known that marine organisms can synthesize bioactive molecules to survive from atypical environmental conditions, such as oxidative stress, photodynamic damage, and extreme temperature. Recent evidence proposed a beneficial role of these compounds for human health. In particular, xanthines, bryostatin, and 11-dehydrosinulariolide displayed encouraging neuroprotective effects in neurodegenerative disorders. This review will focus on the most promising marine drugs’ neuroprotective potential for neurodegenerative disorders, such as Parkinson’s and Alzheimer’s diseases. We will describe these marine compounds’ potential as adjuvant therapies for neurodegenerative diseases, based on their antioxidant, anti-inflammatory, and anti-apoptotic properties.
first_indexed 2024-03-09T05:35:43Z
format Article
id doaj.art-8bc4c1ee159d4cc5b0c621106cf20570
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-09T05:35:43Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-8bc4c1ee159d4cc5b0c621106cf205702023-12-03T12:28:49ZengMDPI AGMarine Drugs1660-33972021-01-011912410.3390/md19010024Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative DisordersMariano Catanesi0Giulia Caioni1Vanessa Castelli2Elisabetta Benedetti3Michele d’Angelo4Annamaria Cimini5Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, AQ, ItalyDepartment of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, AQ, ItalyDepartment of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, AQ, ItalyDepartment of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, AQ, ItalyDepartment of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, AQ, ItalyDepartment of Life, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, AQ, ItalyMarine habitats offer a rich reservoir of new bioactive compounds with great pharmaceutical potential; the variety of these molecules is unique, and its production is favored by the chemical and physical conditions of the sea. It is known that marine organisms can synthesize bioactive molecules to survive from atypical environmental conditions, such as oxidative stress, photodynamic damage, and extreme temperature. Recent evidence proposed a beneficial role of these compounds for human health. In particular, xanthines, bryostatin, and 11-dehydrosinulariolide displayed encouraging neuroprotective effects in neurodegenerative disorders. This review will focus on the most promising marine drugs’ neuroprotective potential for neurodegenerative disorders, such as Parkinson’s and Alzheimer’s diseases. We will describe these marine compounds’ potential as adjuvant therapies for neurodegenerative diseases, based on their antioxidant, anti-inflammatory, and anti-apoptotic properties.https://www.mdpi.com/1660-3397/19/1/24marine drugsneurodegenerative diseasesParkinson’s diseaseAlzheimer’s diseasebrainantioxidants
spellingShingle Mariano Catanesi
Giulia Caioni
Vanessa Castelli
Elisabetta Benedetti
Michele d’Angelo
Annamaria Cimini
Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
Marine Drugs
marine drugs
neurodegenerative diseases
Parkinson’s disease
Alzheimer’s disease
brain
antioxidants
title Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
title_full Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
title_fullStr Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
title_full_unstemmed Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
title_short Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
title_sort benefits under the sea the role of marine compounds in neurodegenerative disorders
topic marine drugs
neurodegenerative diseases
Parkinson’s disease
Alzheimer’s disease
brain
antioxidants
url https://www.mdpi.com/1660-3397/19/1/24
work_keys_str_mv AT marianocatanesi benefitsundertheseatheroleofmarinecompoundsinneurodegenerativedisorders
AT giuliacaioni benefitsundertheseatheroleofmarinecompoundsinneurodegenerativedisorders
AT vanessacastelli benefitsundertheseatheroleofmarinecompoundsinneurodegenerativedisorders
AT elisabettabenedetti benefitsundertheseatheroleofmarinecompoundsinneurodegenerativedisorders
AT micheledangelo benefitsundertheseatheroleofmarinecompoundsinneurodegenerativedisorders
AT annamariacimini benefitsundertheseatheroleofmarinecompoundsinneurodegenerativedisorders